Fostemsavir Tied To Sustained Virologic Response In Heavily Treatment-Experienced HIV-1, Results Show
June 30, 2021
Infectious Disease Advisor (6/29, Lee) reports fostemsavir therapy “in heavily treatment-experienced patients with HIV-1 was found to be associated with sustained virologic response rates through 96 weeks of treatment, according to” phase 3 clinical findi...